Core Viewpoint - The company has adjusted the repurchase price of the 2023 restricted stock incentive plan due to changes in capital structure and dividend distribution, resulting in a new repurchase price of approximately 13.04 yuan per share from the previous 18.26 yuan per share [4][6][7] Summary by Sections Incentive Plan Approval and Disclosure - The company held meetings to approve various related proposals regarding the 2023 restricted stock incentive plan, including the list of incentive objects and management methods [1][2] - Independent directors provided opinions on the incentive plan, and the supervisory board verified the related matters [2][3] Adjustment of Repurchase Price - The adjustment of the repurchase price was necessitated by the company's decision to distribute cash dividends and increase capital reserves, which affects the stock price and total capital [4][5] - The new repurchase price is calculated based on the formula considering the impact of capital increases and stock dividends [5][6] Impact of the Adjustment - The supervisory board confirmed that the adjustment process was appropriate and complied with relevant laws and regulations, ensuring no harm to the company's or shareholders' interests [7]

山东惠发食品股份有限公司 证券代码：603536 证券简称：惠发食品 公告编号：临 2025-028 山东惠发食品股份有限公司（以下简称"公司"或"惠发食品"）第五届监事会第 七次会议通知于 2025 年 8 月 18 日以送达方式通知了全体监事，本次监事会会议于 2025 年 8 月 28 日在公司会议室以现场方式召开。本次会议应出席会议监事 3 名，实际出席 会议监事 3 名，会议由公司监事会主席张英霞女士主持。本次会议的召集和召开符合《公 司法》等有关法律、行政法规、部门规章、规范性文件和《公司章程》的相关规定，会 议形成的决议合法、有效。 二、监事会会议审议情况 具体内容详见公司在上海证券交易所网站(www.sse.com.cn)同日披露的《惠发食品 本议案已经公司第五届董事会审计委员会 2025 年第四次会议审议通过。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 具体内容详见公司在上海证券交易所网站(www.sse.com.cn)同日披露的《惠发食品 关于取消监事会、修订 <公司章程> 及部分制度的公告》（公告编号：2025-022）。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 ...

Core Viewpoint - The company has publicly disclosed the list of individuals eligible for the initial grant under the 2025 Restricted Stock Incentive Plan, ensuring compliance with relevant regulations and guidelines [1][2][3] Disclosure and Verification - The company published the draft of the 2025 Restricted Stock Incentive Plan and the list of initial grant recipients on August 16, 2025, with a public notice period from August 16 to August 25, 2025, lasting at least 10 days [1] - No objections were received regarding the proposed recipients during the public notice period [2] - The Compensation and Assessment Committee verified the eligibility of the proposed recipients, including their identification, employment contracts, and positions held within the company [2] Committee Review and Opinions - The Compensation and Assessment Committee confirmed that all proposed recipients meet the conditions set forth in relevant laws, regulations, and the company's articles of association [3] - The committee's review included checks against disqualifications such as being deemed inappropriate candidates by the stock exchange or regulatory authorities within the last 12 months [2][3]

Core Points - The company has conducted a review of the list of incentive objects for the 2025 restricted stock incentive plan, ensuring compliance with relevant laws and regulations [1][2] - The review confirms that the incentive objects meet the qualifications and conditions set forth in the approved plan [2] Summary by Categories Review Process - The review was conducted by the company's Board of Directors' Compensation and Assessment Committee in accordance with the Company Law, Securities Law, and other relevant regulations [1] - The review focused on the eligibility of the incentive objects as of the grant date [1] Eligibility Criteria - The criteria for disqualifying incentive objects include being recognized as inappropriate by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months, facing administrative penalties for major violations, and other legal restrictions [1] - The committee confirmed that the incentive objects listed are not subject to any of the disqualifying conditions [2] Conclusion - The committee agrees that the conditions for the incentive objects in the 2025 restricted stock incentive plan are legal and valid, and the grant date for the first award is set for 2025 [2]

证券代码：002782 证券简称：可立克 公告编号：2025-069 深圳可立克科技股份有限公司 关于 2023 年限制性股票激励计划部分限制性股 票回购注销完成的公告 公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或者重大遗漏。 特别提示： 部分限制性股票，涉及 58 名激励对象，限制性股票共计 76.80 万股，占本次注 销前公司总股本 496,732,013 股的 0.15%。 股。 深圳可立克科技股份有限公司（以下简称"公司"）于 2025 年 6 月 18 日召 开第五届董事会第十一次会议和第五届监事会第十一次会议，审议通过了《关于 根据《上市公司股权激励管理办法》和公司《2023 年限制性股票激励计划（草 案）》（以下简称"《激励计划》"或"本激励计划"）等相关规定，鉴于本激励计 划第二个解除限售期公司层面业绩考核目标未达成，同意公司对 58 名激励对象 已获授但尚未解除限售的共计 76.80 万股限制性股票进行回购注销。另因公司实 施权益分派，根据公司 2023 年第一次临时股东大会的授权，同意对限制性股票 回购价格进行相应的调整。本次回购事项已经公司 202 ...

Group 1 - The company has implemented an incentive plan involving the allocation of restricted stocks to key personnel, with a total of 337.2696 million shares granted, representing 2.98% of the company's total equity [2] - The allocation of restricted stocks is distributed among various roles, with the largest share going to core technical personnel and management, who received 125.9032 million shares, accounting for 37.33% of the total granted [2] - The reserved portion of the incentive plan consists of 64.0637 million shares, which is 18.99% of the total granted shares [2] Group 2 - The company has confirmed that no individual recipient of the stock incentive plan will exceed 1% of the total equity, and the total number of shares involved in all effective incentive plans will not exceed 20% of the company's total equity [2] - The board of directors has elected Mr. Ma Jianhua as the vice chairman of the company during the same meeting where the incentive plan was discussed [2]

Core Viewpoint - The report outlines the approval and implementation of the 2025 Restricted Stock Incentive Plan for Wuxi Delinhai Environmental Technology Co., Ltd, detailing the necessary procedures and conditions for granting restricted stocks to eligible participants [3][4][14]. Group 1: Approval Process - The incentive plan was approved during the board meeting on July 18, 2025, with subsequent meetings confirming the details and the list of eligible participants [3][4]. - The plan underwent a public disclosure period from July 19 to July 28, 2025, with no objections raised against the proposed participants [4]. - The first extraordinary shareholders' meeting on August 6, 2025, approved the plan and authorized the board to handle related matters [4][5]. Group 2: Granting Details - The first grant date is set for August 28, 2025, with a total of 2.732059 million shares granted, representing 2.42% of the company's total share capital of 113 million shares [6]. - The grant price is established at 11.42 RMB per share, with shares sourced from either repurchased shares or newly issued shares to the participants [6]. - The plan's validity extends up to 48 months, with shares vesting in three phases based on specific timelines and conditions [6][10]. Group 3: Vesting Conditions - The vesting schedule includes 40% of shares vesting after 12 months, 30% after 24 months, and the remaining 30% after 36 months from the grant date [10][12]. - Shares cannot be transferred or used as collateral before they vest, and any additional shares from capital increases will also be subject to the same vesting conditions [12]. Group 4: Impact on Financials - The independent financial advisor recommends that the company account for the costs associated with the incentive plan in accordance with relevant accounting standards, noting potential dilution effects on shareholders [14].

Group 1 - The company held its third extraordinary shareholders' meeting on August 28, 2025, to discuss two key proposals [3][5][7] - The proposals included the repurchase and cancellation of part of the restricted stock from the 2024 incentive plan and changes to the registered capital along with amendments to the company's articles of association [3][6] - The meeting was convened following the board's resolution on August 12, 2025, and the notice was published on August 13, 2025, detailing the meeting's time, location, and voting procedures [2][3] Group 2 - A total of 1 shareholder attended the meeting in person, representing 1,067,395,366 shares, which is 37.9025% of the total voting shares [3][5] - Additionally, 284 shareholders participated via online voting, representing 922,808,888 shares, or 32.7683% of the total voting shares [3][5] - The voting process was conducted both in-person and through the Shanghai Stock Exchange's online voting system, with specific time slots allocated for the online voting [5][6] Group 3 - The first proposal regarding the repurchase and cancellation of restricted stocks received 1,989,843,132 votes in favor, accounting for the majority of the votes cast [6] - The second proposal concerning changes to registered capital and amendments to the articles of association was approved with 1,989,911,122 votes in favor [6][7] - The voting results were verified and confirmed to be in compliance with Chinese laws and the company's articles of association [7]

Core Viewpoint - The legal opinion letter confirms the compliance and legality of Shanghai Medicilon Inc.'s 2025 Restricted Stock Incentive Plan, indicating that the company is qualified to implement this plan and has followed necessary legal procedures [2][20][24]. Group 1: Company Overview - Shanghai Medicilon Inc. is a legally established and validly existing joint-stock company listed on the Shanghai Stock Exchange, with its stock code being 688202 [5][6]. - The company specializes in the research and development of drugs for AIDS, cancer sensitizers, genetic engineering vaccines, and biopharmaceutical intermediates [5]. Group 2: Incentive Plan Details - The 2025 Restricted Stock Incentive Plan involves granting a total of 1 million shares, representing 0.74% of the company's total share capital of 13,435.2184 million shares [7][9]. - The plan includes an initial grant of 800,000 shares (0.60% of total share capital) and a reserved portion of 200,000 shares (0.15% of total share capital) [9][10]. Group 3: Eligibility and Compliance - The incentive plan targets 385 core employees, accounting for 16.39% of the total workforce of 2,349 employees as of December 31, 2024 [7][8]. - The plan's eligibility criteria ensure that no inappropriate candidates are included, adhering to regulations set by the China Securities Regulatory Commission [8][24]. Group 4: Granting and Vesting Conditions - The grant price for the restricted stock is set at 31.37 yuan per share, which is compliant with the higher of the average trading price prior to the plan's announcement [14][15]. - The vesting schedule stipulates that shares will vest in two phases, with the first 50% vesting after 12 months and the remaining 50% after 24 months, contingent on performance targets being met [12][18]. Group 5: Legal Procedures and Disclosure - The company has completed necessary legal procedures, including board and supervisory committee approvals, and is set to disclose relevant documents within two trading days [20][22]. - The company has committed not to provide financial assistance to incentive plan participants, ensuring compliance with regulatory requirements [24].

Core Viewpoint - Shenzhen Oat Technology Co., Ltd. has announced the cancellation of part of the unvested restricted stock from the 2022 incentive plan due to the departure of certain incentive targets, resulting in a total of 206,800 shares being invalidated [1][4][5]. Group 1: Decision Process and Disclosure - The board of directors approved the proposal to cancel part of the unvested restricted stock at the second meeting of the fourth board on August 28, 2025 [1]. - The independent directors provided opinions on whether the 2022 restricted stock incentive plan would benefit the company's sustainable development and whether it would harm the interests of the company and all shareholders [1][2]. - The supervisory board verified the relevant matters of the incentive plan and issued related verification opinions [1][2]. Group 2: Specifics of the Canceled Restricted Stock - The cancellation was based on the regulations of the "Management Measures for Equity Incentives of Listed Companies" and the company's incentive plan, as 12 incentive targets had left the company, disqualifying them from the incentive program [4][5]. - The number of incentive targets for the 2022 plan was adjusted from 45 to 33, with 196,000 shares being canceled [4][5]. Group 3: Impact on the Company - The cancellation of the restricted stock will not have a significant impact on the company's operational situation, nor will it affect the stability of the technical and management teams [5]. - The board's remuneration and assessment committee believes that the cancellation aligns with relevant laws and regulations and does not harm the interests of the company and its shareholders [5][6]. Group 4: Legal Opinions - Guangdong Xinda Law Firm concluded that the adjustments and cancellations related to the 2022 incentive plan have received the necessary approvals and authorizations, and the conditions for vesting have been met [6][7].